Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-29 @ 3:31 AM
Study NCT ID:
NCT05495932
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2022-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mepolizumab Pharmacokinetics Among Patients With Severe Asthma
Sponsor:
University Hospital, Montpellier
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RECHMPL22_0035
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None